{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:20:15Z","timestamp":1790626815643,"version":"4.1.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["bprch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.beha.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T00:46:01Z","timestamp":1369269961000},"page":"57-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Molecular underpinning of extranodal NK\/T-cell lymphoma"],"prefix":"10.1016","volume":"26","author":[{"given":"Yenlin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2013.04.006_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","article-title":"Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification","volume":"8","author":"Ascani","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib3","first-page":"216","article-title":"Angioimmunoblastic T-cell lymphoma (AITL) is the most prevalent T-cell lymphoma entity in Western Europe","volume":"5","author":"Parrens","year":"2012","journal-title":"J Hematopathol"},{"key":"10.1016\/j.beha.2013.04.006_bib4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","article-title":"The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists","volume":"50","year":"2000","journal-title":"Pathol Int"},{"key":"10.1016\/j.beha.2013.04.006_bib5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1080\/10428194042000198849","article-title":"Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors","volume":"45","author":"Chang","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2013.04.006_bib6","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Armitage","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/10428190109057982","article-title":"Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis","volume":"41","author":"Morice","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2013.04.006_bib8","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib9","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2013.04.006_bib10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","article-title":"NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series","volume":"117","author":"Mansoor","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib11","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/blood-2010-06-290650","article-title":"Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation","volume":"116","author":"Takeuchi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib12","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.beha.2013.04.006_bib13","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2559.2008.02997.x","article-title":"Nodal T\/NK-cell lymphoma of nasal type: a clinicopathological study of six cases","volume":"52","author":"Takahashi","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2013.04.006_bib15","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","article-title":"CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas","volume":"87","author":"Emile","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/PAS.0b013e31821ec4b5","article-title":"Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK\/T-cell lymphoma, nasal type, with EBV subtyping analysis","volume":"35","author":"Gualco","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib17","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G","article-title":"Clinicopathologic and genotypic study of extranodal nasal-type natural killer\/T-cell lymphoma and natural killer precursor lymphoma among Koreans","volume":"89","author":"Ko","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib18","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0002-9440(10)63014-3","article-title":"Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas","volume":"159","author":"Lin","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","article-title":"Nasal-type extranodal natural killer\/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore","volume":"17","author":"Ng","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/(SICI)1097-0215(19990611)81:6<865::AID-IJC5>3.0.CO;2-S","article-title":"Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology","volume":"81","author":"Ohsawa","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/10428199909169621","article-title":"Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene","volume":"35","author":"Suzumiya","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2013.04.006_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","article-title":"Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta\/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study","volume":"36","author":"Pongpruttipan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib23","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood.V95.11.3628","article-title":"Expression of CD94\/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas","volume":"95","author":"Haedicke","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jcp.54.3.224","article-title":"Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype","volume":"54","author":"Dukers","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib25","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2003-01-0295","article-title":"CD94 transcripts imply a better prognosis in nasal-type extranodal NK\/T-cell lymphoma","volume":"102","author":"Lin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib26","series-title":"Extranodal lymphomas: pathology and management","author":"Cavalli","year":"2008"},{"key":"10.1016\/j.beha.2013.04.006_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/1097-0142(19850815)56:4<814::AID-CNCR2820560419>3.0.CO;2-P","article-title":"Primary lymphomas of the nasal cavity and paranasal sinuses","volume":"56","author":"Robbins","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2214\/ajr.174.4.1741141","article-title":"Nasal T-cell\/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity","volume":"174","author":"Ooi","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.beha.2013.04.006_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0037-1963(03)00136-7","article-title":"Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas\/leukemias","volume":"40","author":"Cheung","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.beha.2013.04.006_bib31","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood-2008-05-160176","article-title":"Clinical features and treatment outcome of nasal-type NK\/T cell lymphoma of Waldeyer's ring","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hon.847","article-title":"Extranodal NK\/T-cell lymphoma: diagnosis and treatment cues","volume":"26","author":"Suzuki","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/106689690401200410","article-title":"Nasal NK\/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities","volume":"12","author":"Kuo","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib34","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2006-07-033142","article-title":"Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK\/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials","volume":"109","author":"Bossard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib35","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)\/II(E) extranodal NK\/T-cell lymphoma, nasal type","volume":"106","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib36","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02983387","article-title":"L-asparaginase-based regimen in the treatment of refractory midline nasal\/nasal-type T\/NK-cell lymphoma","volume":"78","author":"Yong","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.beha.2013.04.006_bib38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00277-008-0669-3","article-title":"L-asparaginase in the treatment of refractory and relapsed extranodal NK\/T-cell lymphoma, nasal type","volume":"88","author":"Yong","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2013.04.006_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hon.765","article-title":"Midline NK\/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors","volume":"24","author":"Yong","year":"2006","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib40","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdn542","article-title":"L-asparaginase-based treatment of 15 western patients with extranodal NK\/T-cell lymphoma and leukemia and a review of the literature","volume":"20","author":"Jaccard","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib42","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","article-title":"Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study","volume":"117","author":"Jaccard","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2009.07802.x","article-title":"Advances in the management and monitoring of extranodal NK\/T-cell lymphoma, nasal type","volume":"147","author":"Liang","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.04.006_bib44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.leu.2401778","article-title":"Malignant hematopoietic cell lines: in\u00a0vitro models for the study of natural killer cell leukemia-lymphoma","volume":"14","author":"Drexler","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.006_bib45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0145-2126(02)00055-3","article-title":"Multicolor-FISH analysis of a natural killer cell line (NK-92)","volume":"26","author":"MacLeod","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2013.04.006_bib46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0145-2126(03)00024-9","article-title":"Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma","volume":"27","author":"Matsuo","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2013.04.006_bib47","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/10428190802043879","article-title":"An Epstein-Barr virus positive natural killer lymphoma xenograft derived for drug testing","volume":"49","author":"Loong","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2013.04.006_bib48","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.leu.2402239","article-title":"Characterization of two novel cell lines, DERL-2 (CD56+\/CD3+\/Tcry5+) and DERL-7 (CD56+\/CD3-\/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma","volume":"15","author":"Di Noto","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.006_bib49","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/leu.2009.91","article-title":"STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK\/T-cell lymphoma","volume":"23","author":"Coppo","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.006_bib50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ni0903-815","article-title":"What is trogocytosis and what is its purpose?","volume":"4","author":"Joly","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2013.04.006_bib51","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1189\/jlb.0508278","article-title":"Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells","volume":"84","author":"Poupot","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.beha.2013.04.006_bib52","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2005-06-2569","article-title":"IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines","volume":"107","author":"Kis","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib53","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/1078-0432.CCR-05-1426","article-title":"Expression of interleukin-9 in nasal natural killer\/T-cell lymphoma cell lines and patients","volume":"11","author":"Nagato","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib54","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)65667-2","article-title":"Human interleukin-10 expression in T\/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas","volume":"153","author":"Boulland","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.bjc.6602968","article-title":"Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK\/T-cell lymphoma and chronic active EBV infection","volume":"94","author":"Zhang","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","article-title":"The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family","volume":"80","author":"Mosialos","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.beha.2013.04.006_bib57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.beha.2013.04.006_bib58","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.2823","article-title":"Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK\/T cell lymphoma revealed by gene expression profiling","volume":"223","author":"Ng","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib60","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/leu.2010.255","article-title":"Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in\u00a0vitro","volume":"25","author":"Iqbal","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.006_bib61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib62","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.006_bib63","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","article-title":"Consistent patterns of allelic loss in natural killer cell lymphoma","volume":"157","author":"Siu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib64","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)65454-5","article-title":"Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia. Recognition of consistent patterns of genetic alterations","volume":"155","author":"Siu","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cancergencyto.2005.06.025","article-title":"Chromosome band 6q deletion pattern in malignant lymphomas","volume":"165","author":"Taborelli","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.beha.2013.04.006_bib66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cyto.1069","article-title":"Comparative genomic hybridization study of nasal-type NK\/T-cell lymphoma","volume":"46","author":"Ko","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.beha.2013.04.006_bib67","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1365-2141.2003.04419.x","article-title":"A 2.6\u00a0Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer\/T-cell lymphoma","volume":"122","author":"Sun","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.04.006_bib68","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","article-title":"Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses","volume":"118","author":"Karube","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0092-8674(94)90321-2","article-title":"Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells","volume":"77","author":"Turner","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.beha.2013.04.006_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20052204","article-title":"Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma","volume":"203","author":"Pasqualucci","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2013.04.006_bib71","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/ni1321","article-title":"Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance","volume":"7","author":"Kallies","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2013.04.006_bib72","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature03029","article-title":"The role of autophagy during the early neonatal starvation period","volume":"432","author":"Kuma","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.beha.2013.04.006_bib73","first-page":"2527","article-title":"Isolation and characterization of genes associated with chromosome-6 mediated tumor suppression in human malignant melanoma","volume":"12","author":"Ray","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2013.04.006_bib74","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor suppressor gene in natural killer cell malignancies","volume":"108","author":"Kucuk","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2013.04.006_bib75","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1182\/blood-2002-06-1785","article-title":"Common mechanism for oncogenic activation of MLL by forkhead family proteins","volume":"101","author":"So","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib76","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/1078-0432.CCR-08-0124","article-title":"A new fork for clinical application: targeting forkhead transcription factors in cancer","volume":"15","author":"Yang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajpath.2012.09.012","article-title":"HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms","volume":"182","author":"Kucuk","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib78","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/hmg\/ddh215","article-title":"Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney","volume":"13","author":"Anglesio","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beha.2013.04.006_bib79","first-page":"1581","article-title":"Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer","volume":"28","author":"Hibi","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib80","first-page":"2231","article-title":"Methylation of HACE1 in gastric carcinoma","volume":"29","author":"Sakata","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib81","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm1621","article-title":"The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers","volume":"13","author":"Zhang","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2013.04.006_bib82","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/10428190701817282","article-title":"Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia","volume":"49","author":"Thelander","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2013.04.006_bib83","first-page":"4855","article-title":"Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis","volume":"54","author":"Greenblatt","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib84","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1634\/theoncologist.7-1-73","article-title":"Molecular aspects of the mammalian cell cycle and cancer","volume":"7","author":"Sandal","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.beha.2013.04.006_bib85","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","article-title":"p53 mutations in nasal natural killer\/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease","volume":"159","author":"Quintanilla-Martinez","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib86","first-page":"265","article-title":"p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK\/T-cell lymphoma in Korea and Japan","volume":"13","author":"Hongyo","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.beha.2013.04.006_bib87","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1146\/annurev.bi.62.070193.004223","article-title":"Function and regulation of ras","volume":"62","author":"Lowy","year":"1993","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.beha.2013.04.006_bib88","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.1073\/pnas.85.23.9268","article-title":"Analysis of RAS oncogene mutations in human lymphoid malignancies","volume":"85","author":"Neri","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2013.04.006_bib89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1349-7006.2003.tb01436.x","article-title":"Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK\/T cell lymphoma in northeast district of China","volume":"94","author":"Hoshida","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1016\/j.beha.2013.04.006_bib90","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1349-7006.2002.tb01234.x","article-title":"Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms","volume":"93","author":"Sugimoto","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib91","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2003.08.025","article-title":"P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK\/T-cell lymphoma from Hokkaido, Japan","volume":"35","author":"Takahara","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib92","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/gb-2003-4-10-r69","article-title":"An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets","volume":"4","author":"Zeller","year":"2003","journal-title":"Genome Biol"},{"key":"10.1016\/j.beha.2013.04.006_bib93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/labinvest.3700509","article-title":"Wnt signaling and human diseases: what are the therapeutic implications?","volume":"87","author":"Luo","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.beha.2013.04.006_bib94","first-page":"2345","article-title":"Specific c-kit mutations in sinonasal natural killer\/T-cell lymphoma in China and Japan","volume":"60","author":"Hongyo","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib95","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2141.2003.04396.x","article-title":"Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas","volume":"122","author":"Siu","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.04.006_bib96","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9440(10)64349-0","article-title":"Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved","volume":"160","author":"Siu","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib97","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-0609.2005.00417.x","article-title":"Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1\/Cip1, p27Kip1 and p73) in natural killer cell disorders","volume":"74","author":"Kawamata","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2013.04.006_bib98","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","article-title":"The INK4a\/ARF locus and melanoma","volume":"22","author":"Sharpless","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2013.04.006_bib99","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.95.12.6870","article-title":"Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma","volume":"95","author":"Herman","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2013.04.006_bib100","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/jnci\/92.16.1303","article-title":"Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas","volume":"92","author":"Virmani","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2013.04.006_bib101","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/jnci\/92.10.826","article-title":"Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer","volume":"92","author":"Widschwendter","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2013.04.006_bib102","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.1997.2880887.x","article-title":"Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage","volume":"31","author":"Ohshima","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2013.04.006_bib103","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)64490-2","article-title":"Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer\/T-cell lymphoma","volume":"161","author":"Shen","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib104","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/sj.onc.1205571","article-title":"Frequent mutations of Fas gene in nasal NK\/T cell lymphoma","volume":"21","author":"Takakuwa","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2013.04.006_bib105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.beha.2009.05.001","article-title":"Gene expression profiling in lymphoma diagnosis and management","volume":"22","author":"Iqbal","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.beha.2013.04.006_bib106","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood.V90.10.4099","article-title":"The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease","volume":"90","author":"Teruya-Feldstein","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib107","series-title":"Analyse des alt\u00e9rations oncog\u00e9niques associ\u00e9es aux lymphomes NK\/T de type nasal [Public]","author":"Huang","year":"2009"},{"key":"10.1016\/j.beha.2013.04.006_bib108","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.beha.2013.04.006_bib109","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.23778","article-title":"Genetic aberrations of gastrointestinal stromal tumors","volume":"113","author":"Yang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib110","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1245\/s10434-007-9480-y","article-title":"Dermatofibrosarcoma protuberans: recent clinical progress","volume":"14","author":"McArthur","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib111","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.bjc.6605225","article-title":"Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas","volume":"101","author":"Martinho","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/modpathol.3800989","article-title":"Platelet-derived growth factor receptor expression and amplification in choroid plexus carcinomas","volume":"21","author":"Nupponen","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib113","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ijc.23432","article-title":"Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas","volume":"123","author":"Toepoel","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib114","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jmg.2004.024034","article-title":"A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas","volume":"42","author":"De Bustos","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.beha.2013.04.006_bib115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2009.01.001","article-title":"Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders","volume":"23","author":"Valent","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.beha.2013.04.006_bib116","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib117","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2013.04.006_bib118","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/nm.2966","article-title":"PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas","volume":"18","author":"Laimer","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2013.04.006_bib119","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00277-008-0539-z","article-title":"The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas","volume":"87","author":"Chen","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2013.04.006_bib120","first-page":"198","article-title":"Aberrant PDGFRA signalling is sustained by an autocrine loop in peripheral T-cell lymphoma not otherwise specified (abstract)","volume":"1","author":"Piccaluga","year":"2008","journal-title":"J Hematop"},{"key":"10.1016\/j.beha.2013.04.006_bib121","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer\u2013new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.beha.2013.04.006_bib122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.beha.2013.04.006_bib123","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1172\/JCI3785","article-title":"Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth In\u00a0vitro","volume":"102","author":"Grandis","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2013.04.006_bib124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.beha.2013.04.006_bib125","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1038\/sj.onc.1207703","article-title":"Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma","volume":"23","author":"Amin","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2013.04.006_bib126","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1038\/sj.onc.1206849","article-title":"Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma","volume":"22","author":"Amin","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2013.04.006_bib127","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/leu.2008.129","article-title":"Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma","volume":"22","author":"Bard","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.006_bib128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm1249","article-title":"Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target","volume":"11","author":"Chiarle","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2013.04.006_bib129","first-page":"3692","article-title":"Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma","volume":"9","author":"Khoury","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib130","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/S0002-9440(10)63781-9","article-title":"Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma","volume":"164","author":"Lai","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib131","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1172\/JCI29401","article-title":"Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes","volume":"116","author":"Piva","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2013.04.006_bib132","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","article-title":"Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma","volume":"2","author":"Koo","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beha.2013.04.006_bib133","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib134","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2004-07-2909","article-title":"The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications","volume":"105","author":"Podar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib135","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2013.04.006_bib136","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1172\/JCI8978","article-title":"Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration","volume":"106","author":"Dias","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2013.04.006_bib137","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1073\/pnas.191117498","article-title":"Inhibition of both paracrine and autocrine VEGF\/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias","volume":"98","author":"Dias","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2013.04.006_bib138","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2559.2005.02081.x","article-title":"The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study","volume":"46","author":"Pillai","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2013.04.006_bib139","first-page":"728","article-title":"Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies","volume":"59","author":"Bellamy","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<369::AID-PATH381>3.0.CO;2-X","article-title":"Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1\/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival","volume":"188","author":"Decaussin","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib141","first-page":"2719","article-title":"Vascular endothelial growth factor and cellular chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion","volume":"7","author":"Hayashibara","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2013.04.006_bib142","first-page":"iv113","article-title":"Correlation between Epstein-Barr virus (EBV) RNA expression and vascular endothelial growth factor (VEGF) expression in different subtypes of peripheral T-cell lymphomas (PTCL) and prognostic implications (abstract)","volume":"19","author":"Jorgensen","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2013.04.006_bib143","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrd2530","article-title":"Drug development of MET inhibitors: targeting oncogene addiction and expedience","volume":"7","author":"Comoglio","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.beha.2013.04.006_bib144","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.anndiagpath.2007.12.001","article-title":"Current overview of the role of Akt in cancer studies via applied immunohistochemistry","volume":"12","author":"Shtilbans","year":"2008","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.beha.2013.04.006_bib145","first-page":"274","article-title":"AKT plays a role in the survival of the tumor cells of extranodal NK\/T-cell lymphoma, nasal type","volume":"90","author":"Chow","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2013.04.006_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2012.12.022","article-title":"Comprehensive gene expression profiles of NK cell neoplasms identify vorinostat as an effective drug candidate","author":"Karube","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beha.2013.04.006_bib147","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3324\/haematol.2012.068510","article-title":"Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas","volume":"98","author":"Martin-Sanchez","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2013.04.006_bib148","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood-2009-06-222794","article-title":"Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma\/leukemia","volume":"114","author":"Yamanaka","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib149","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1182\/blood-2011-07-364224","article-title":"Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer\/T-cell lymphoma","volume":"118","author":"Ng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.006_bib150","doi-asserted-by":"crossref","first-page":"e42193","DOI":"10.1371\/journal.pone.0042193","article-title":"MicroRNA profiling of Epstein-Barr virus-associated NK\/T-cell lymphomas by deep sequencing","volume":"7","author":"Motsch","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T01:43:56Z","timestamp":1595814236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692613000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1521692613000078"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.006","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular underpinning of extranodal NK\/T-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}